366 related articles for article (PubMed ID: 19466963)
1. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study.
el-Darouti M; Marzouk S; Abdel Hay R; el-Tawdy A; Fawzy M; Leheta T; Gammaz H; Al Gendy N
Br J Dermatol; 2009 Aug; 161(2):313-9. PubMed ID: 19466963
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity.
D'Auria L; Bonifati C; Mussi A; D'Agosto G; De Simone C; Giacalone B; Ferraro C; Ameglio F
Eur Cytokine Netw; 1997 Dec; 8(4):383-7. PubMed ID: 9459618
[TBL] [Abstract][Full Text] [Related]
3. Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial.
El-Darouti MA; Hegazy RA; Abdel Hay RM; El Hawary MS; Tawdy AM; Fawzy MM; Rashed LA
Arch Dermatol Res; 2015 May; 307(4):299-307. PubMed ID: 25450635
[TBL] [Abstract][Full Text] [Related]
4. Stress and serum TNF-alpha levels may predict disease outcome in patients with pemphigus: a preliminary study.
Ragab N; Abdallah M; El-Gohary E; Elewa R
Cutis; 2011 Apr; 87(4):189-94. PubMed ID: 21644493
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
de Moura FJ; Leal PP; de Souza Furtado R; Muniz-Junqueira MI; Veiga JP
Toxicology; 2008 Jan; 243(1-2):66-74. PubMed ID: 18022309
[TBL] [Abstract][Full Text] [Related]
6. The effects of pentoxifylline on the myocardial inflammation and ischemia-reperfusion injury during cardiopulmonary bypass.
Ustunsoy H; Sivrikoz MC; Tarakcioglu M; Bakir K; Guldur E; Celkan MA
J Card Surg; 2006; 21(1):57-61. PubMed ID: 16426349
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid.
El Darouti MA; Fakhry Khattab MA; Hegazy RA; Hafez DA; Gawdat HI
Eur J Ophthalmol; 2011; 21(5):529-37. PubMed ID: 21279976
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
9. Effects of pentoxifylline on the cytokines that may play a role in rejection and resistive index in renal transplant recipients.
Demir E; Paydas S; Balal M; Kurt C; Sertdemir Y; Erken U
Transplant Proc; 2006 Nov; 38(9):2883-6. PubMed ID: 17112855
[TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: A pilot study.
Dogra D; Dogra NK; Gupta N; Gupta V
Indian J Dermatol Venereol Leprol; 2015; 81(6):640-2. PubMed ID: 26515856
[No Abstract] [Full Text] [Related]
11. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
12. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
Selim K; Hüseyin C; Ibrahim KH; Hasan BU; Kazim U; Hüseyin K
Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
[TBL] [Abstract][Full Text] [Related]
13. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of infliximab in active SLE: a pilot study.
Uppal SS; Hayat SJ; Raghupathy R
Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
[TBL] [Abstract][Full Text] [Related]
15. The role of TNF-alpha in patients with chronic low back pain-a prospective comparative longitudinal study.
Wang H; Schiltenwolf M; Buchner M
Clin J Pain; 2008; 24(3):273-8. PubMed ID: 18287835
[TBL] [Abstract][Full Text] [Related]
16. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
[TBL] [Abstract][Full Text] [Related]
18. [Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy].
Balázs C; Kiss E; Vámos A; Molnár I; Farid NR
Orv Hetil; 1997 Nov; 138(45):2869-74. PubMed ID: 9432636
[TBL] [Abstract][Full Text] [Related]
19. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy.
Keskin DB; Stern JN; Fridkis-Hareli M; Razzaque Ahmed A
Cytokine; 2008 Mar; 41(3):315-21. PubMed ID: 18289869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
